Italian IVDs (in vitro diagnostics) growth sustained over the E1 billion mark:
This article was originally published in Clinica
The Italian IVDs market grew by just over 2% in 2003, from euro1.097bn ($1.32bn) to euro1.121bn, and by more than 5% over the last five years, according to a report published by diagnostics and biomedical industry association Assobiomedica. The market segment that showed greatest growth was glycaemia self-monitoring kits, which has grown more than 10% since 1999, to euro219m. For further details of Assobiomedica's 2003 IVDs report and views from the association on the prospects for Italy's wider medical technology industry, see the next issue of Clinica.